We previously reported that elevated expression of syndecan-2 potentiates the tumorigenic activity of colon carcinoma cells [7, 11, 27–29] but the exact molecular regulatory mechanism underlying this effect was not known. The gene discussed is SDC2; the disease is colon carcinoma.